Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -27.06
- Piotroski Score 3.00
- Grade Perform
- Symbol (CTIC)
- Company CTI BioPharma Corp.
- Price $9.10
- Changes Percentage (0.06%)
- Change $0.01
- Day Low $9.09
- Day High $9.10
- Year High $9.10
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.; S*BIO Pte Ltd.; and Baxalta. The company was formerly known as Cell Therapeutics, Inc. and changed its name to CTI BioPharma Corp. in May 2014. CTI BioPharma Corp. was incorporated in 1991 and is headquartered in Seattle, Washington.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 08/07/2023
- Fiscal Year End N/A
- Average Stock Price Target $9.00
- High Stock Price Target $13.00
- Low Stock Price Target $9.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.54
- Trailing P/E Ratio -16.842592592593
- Forward P/E Ratio -16.842592592593
- P/E Growth -16.842592592593
- Net Income $-91,041,000
Income Statement
Quarterly
Annual
Latest News of CTIC
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Collier lifts Minnesota past Connecticut to move within one win of WNBA finals
In Game 3 of WNBA semi-finals, Minnesota Lynx defeated Connecticut Sun 90-81, led by Collier's 26 points. After a tough offensive game, Collier stepped up, sealing the win and giving Lynx a 2-1 series...
By The Guardian | 16 hours ago -
Minnesota Lynx cruise to Game 3 win vs. Connecticut Sun, close in on WNBA Finals
Minnesota Lynx took a 2-1 lead in the series against Connecticut Sun, dominating with a strong offense led by Collier, Williams, and McBride. Connecticut's efforts fell short despite a balanced scorin...
By USA Today | 17 hours ago -
Investigation into Denver Fire Department comp time practices "nearing its conclusion"
A city-commissioned investigation into Denver Fire Department commanders' use of comp time nears completion after over five months. Chief Desmond Fulton accrued hundreds of hours for personal activiti...
By CBS News | 20 hours ago